Advances in Hepatology

Advances in Hepatology

This book discusses clinical advances in hepatology, with a focus on metabolic diseases and chronic hepatitis C. The development of direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection in 2010 has completely transformed the management of this disease. This tran...

Full description

Bibliographic Details
Format:	eBook
Language:	English
Published:	IntechOpen 2021
Subjects:	Hepatology cirrhosis, hepatitis c, chronic hepatitis c, bacteria, hepatocellular carcinoma, gene expression
Online Access:	Open Access: DOAB: description of the publication Open Access: DOAB, download the publication

Similar Items

An unfortunate failure: multifocal hepatocellular carcinoma in a non-cirrhotic patient with chronic hepatitis C treated with ledipasvir/sofosbuvir
by: Megan Sue Soliman, et al.
Published: (2018-05-01)

Epidemiología molecular del virus de la hepatitis C
by: Karina Salvatierra

Substernal Mass: A Rare Presentation of Hepatocellular Carcinoma
by: Kevin Yuqi Wang, et al.
Published: (2019-11-01)

Clinicopathologic features of dual chronic hepatitis B and C infection: A comparison with single hepatitis B, C and delta infections
by: Hakan Senturk, et al.
Published: (2008-01-01)

FATE OF PATIENTS WITH LATE-DETECTED HEPATITIS C INFECTION - CASE REPORTS
by: Velimir Kostić, et al.
Published: (2011-06-01)

Hepatogenous diabetes. Current views of an ancient problem
by: Diego García-Compean, et al.
Published: (2009-01-01)

Hepatitis C From Infection to Cure
Published: (2018)

Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience
by: Eun Ju Cho, et al.
Published: (2012-06-01)

Hepatocellular carcinoma: Epidemiological profile from a cohort of federal employees in Mexico
by: Laura Ladrón de Guevara,, et al.
Published: (2009-07-01)

Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment
by: Ming-Tsung Lin, et al.
Published: (2021-01-01)

Prognostic value of serum autotaxin in liver cirrhosis and prediction of hepatocellular carcinoma
by: Nagwa Ramadan Ahmed, et al.
Published: (2019-01-01)

The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance
by: Cortlandt M. Sellers, et al.
Published: (2019-10-01)

Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
by: Khaled Mohieldeen, et al.
Published: (2021-09-01)

Liver disease referrals to an urban, hospital‐based hepatology outpatient clinic over the past 25 years
by: Micah Grubert Van Iderstine, et al.
Published: (2020-06-01)

Newer direct-acting antivirals for hepatitis C virus infection: Perspectives for India
by: Varun Gupta, et al.
Published: (2017-01-01)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
by: Ming-Lun Yeh, et al.
Published: (2021-07-01)

Management of Chronic Liver Diseases Recent Advances
Published: (2018)

Association between hepatitis C and hepatocellular carcinoma
by: Luis Jesuino de Oliveira Andrade, et al.
Published: (2009-01-01)

IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT-RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS
by: Kelly Fernanda Nomura DRESCH, et al.
Published: (2016-01-01)

Hepatitis C Recent Advances
Published: (2023)

The Patient Bomb: Sustained Viral Response after Hepatitis C in Cirrhosis
by: Rui António Rocha Tato Marinho
Published: (2020-02-01)

Direct-acting antivirals: a new strategy in the treatment of hepatitis C virus infection in patients with cirrhosis
by: Mariana Avricenco
Published: (2019-12-01)

Association of Polymorphisms in the Glutathione S-Transferase Theta-1 Gene with Cirrhosis and Hepatocellular Carcinoma in Brazilian Patients with Chronic Hepatitis C
by: Oscar C. Araujo, et al.
Published: (2021-07-01)

Hepatocellular carcinoma in a hepatitis C patient with sustained viral response and no fibrosis
by: James H. Tabibian, et al.
Published: (2009-01-01)

Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies
by: Xiaofei Li, et al.
Published: (2021-01-01)

Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
by: Xiaofei Li, et al.
Published: (2020-04-01)

Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma
by: Byung Soo Kwan, et al.
Published: (2021-03-01)

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
by: Chung-Feng Huang, et al.
Published: (2019-03-01)

Epidemiology of Chronic Hepatitis C Infections at a Tertiary Care Centre in Oman
by: Said A. Al-Busafi, et al.
Published: (2018-01-01)

Biomarkers development for early detection of cancer: Reducing the burden of cancer in the ageing society
by: Paneghetti Laura, et al.
Published: (2018-01-01)

A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
by: Suofeng Sun, et al.
Published: (2019-10-01)

Particularidades del carcinoma hepatocelular en los pacientes con cirrosis hepática Special features of hepatocellular carcinoma in patients presenting with liver cirrhosis
by: Marlen Ivón Castellanos Fernández, et al.
Published: (2011-03-01)

Improving Knowledge of Hepatitis C Screening Guidelines Among a Population of Family Medicine Residents
by: Jones, Curry, et al.
Published: (2018)

Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin
by: Ng KJ, et al.
Published: (2016-08-01)

Vitamin D receptor gene polymorphisms and risk of hepatocellular carcinoma in hepatitis C-related liver cirrhosis
by: Ghada M. Galal, et al.
Published: (2021-01-01)

Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma
by: Valli De Re, et al.
Published: (2019-03-01)

Hepatology Center for the Management of Patients with Hepatitis: Proposed electronic health record
by: Georgios Skapetis, et al.
Published: (2012-01-01)

Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort
by: Tiago Pereira Guedes, et al.
Published: (2019-10-01)

Successful antiviral therapy for chronic hepatitis C in a patient after surgery for hepatocellular carcinoma (a clinical observation)
by: I. G. Nikitin, et al.
Published: (2018-08-01)

GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients
by: Clemens Schotten, et al.
Published: (2021-07-01)